EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ertapenem Pharmacokinetics in Equine Plasma and Synovial Fluid After Administration via Continuous Rate Infusion

Alexa R Bish-Jones iD, Mark G Papich iD, James A Orsini iD

Journal of Veterinary Pharmacology and Therapeutics · 20.11.2026

DOI: 10.1111/jvp.70122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 20.11.2026. Verfasst von Alexa R Bish-Jones und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roemer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study describes the pharmacokinetics of ertapenem as a continuous rate infusion (CRI) administered to horses at a rate of 3.75 mg/kg/h. Blood (30, 60, 120, 360, 480 min) and synovial (60, 120, 240, 360 min) samples were collected throughout the 8‐hour infusion. Pharmacokinetic analysis was performed with noncompartmental methods. Parameters calculated included partial area under the curve (AUC), maximum concentration ( C max ), and clearance (CL). In plasma, the C max was 47.10 μg/mL (CV = 21.69%) and CL was 97.86 mL/kg/h (CV 17.83%). In synovial fluid, the C max was 25.71 μg/mL (CV 33.49%). The ratio of the synovial fluid to plasma concentration of ertapenem was 35.86% (CV 14.7%) and 54.58% (CV 22%) for AUC and C max , respectively. These values represent the extent of penetration from the plasma to synovial fluid. Ertapenem was well tolerated, although it caused transient soft feces in three horses. Ertapenem use in horses should be reserved for cases where culture and susceptibility results support administration and the isolated bacteria are not susceptible to other antimicrobials. Administration via continuous rate infusion is convenient for intensive care facilities and extended orthopedic surgery cases in reducing development of resistance by decreasing the total time below MIC and total drug administered.

Schlagwörter

Stichwörter der Autor:innen

antimicrobialertapenemhorsepharmacokineticsynovial fluid

Autor:innen und Institutionen

  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
  • Department of Large Animal Medicine, University of Georgia, Athens, Georgia, USA.
  • Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Alexa R Bish-Jones, Mark G Papich, James A Orsini

Förderung

  • Roemer Foundation

Zitieren

APA

Bish-Jones, A. R., Papich, M. G., & Orsini, J. A. (2026). Ertapenem Pharmacokinetics in Equine Plasma and Synovial Fluid After Administration via Continuous Rate Infusion. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70122

Vancouver

Bish-Jones AR, Papich MG, Orsini JA. Ertapenem Pharmacokinetics in Equine Plasma and Synovial Fluid After Administration via Continuous Rate Infusion. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70122

BibTeX
@article{BishJones2026,
  author = {Bish-Jones, Alexa R and Papich, Mark G and Orsini, James A},
  title = {Ertapenem Pharmacokinetics in Equine Plasma and Synovial Fluid After Administration via Continuous Rate Infusion},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2026},
  doi = {10.1111/jvp.70122}
}
Kostenlos starten →